A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors

Clinical trial NCT04943900 · COMPLETED

Trial details

NCT number: NCT04943900
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2021-08-09
Primary completion: 2025-02-27
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.